Home › Coronary Artery Disease › Florida › Hialeah
Coronary Artery Disease clinical trials in Hialeah, FL
3 studies for Coronary Artery Disease are looking for participants at sites in and around Hialeah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Inpatient Research Clinic, LLC, Miami Lakes · 4 mi away
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- New Generation of Medical Research, LLC., Hialeah
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Family First Medical Research Center, Hialeah Gardens · 3 mi away
- Floridian Clinical Research, Miami Lakes · 4 mi away
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY22 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Dallas, TX15 studies
- Cleveland, OH14 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- Columbus, OH10 studies
- Los Angeles, CA9 studies
- Philadelphia, PA9 studies
Other studies in Hialeah
- Obesity13 studies
- Schizophrenia13 studies
- Heart Failure12 studies
- Type 2 Diabetes10 studies
- Overweight10 studies
- Steatotic Liver Disease9 studies
- Atherosclerosis8 studies
- COPD8 studies
- Major Depressive Disorder8 studies
- Cardiovascular Disease6 studies
- Alzheimer's Disease6 studies
- Cancer (all types)6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.